Resting NK cells from healthy donors were challenged against different BCP-ALL primary blasts with CD19-NKCEs (or IC-NKCEs) in cytotoxicity and degranulation assays (Fig. 3D). Here, CD19 is linked to acute lymphoblastic leukemia.